683 Capital Management LLC Decreases Holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

683 Capital Management LLC lessened its stake in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Rating) by 41.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,000,000 shares of the biotechnology company’s stock after selling 705,000 shares during the period. 683 Capital Management LLC […]

Related Keywords

Montreal ,Quebec ,Canada ,Iovance Biotherapeutics ,Stifel Nicolaus ,Capital Management ,Wells Fargo Company ,Strategic Wealth Advisors Group ,Iovance Biotherapeutics Company Profile ,Nasdaq ,Iovance Biotherapeutics Inc ,Bioimpact Capital ,Cubist Systematic Strategies ,Get Rating ,Systematic Strategies ,Montreal Can ,Wealth Advisors Group ,